| Trial ID: | L7272 |
| Source ID: | NCT00738153
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir
|
| Outcome Measures: |
Primary: The incidence of serious adverse drug reactions, including major hypoglycaemic events, From baseline to 12 and 24 weeks of Levemir® therapy, respectively | Secondary: Number of serious adverse events, From baseline to 12 and 24 weeks of Levemir® therapy, respectively|Number of all adverse events, From baseline to 12 and 24 weeks of Levemir® therapy, respectively|Number of all hypoglycaemic events, in the 4 weeks preceding the visits at 12 weeks and 24 weeks.|Weight changes, at the end of study|HbA1c, at the end of study|Sub -group analysis of hypo risk, From baseline to 12 and 24 weeks of Levemir® therapy, respectively
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
798
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-06
|
| Completion Date: |
2009-05
|
| Results First Posted: |
|
| Last Update Posted: |
2014-08-15
|
| Locations: |
Casablanca, 20000, Morocco
|
| URL: |
https://clinicaltrials.gov/show/NCT00738153
|
